These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effect of heterogeneity of rabies virus strain and challenge route on efficacy of inactivated rabies vaccines in mice. Wunderli PS; Dreesen DW; Miller TJ; Baer GM Am J Vet Res; 2003 Apr; 64(4):499-505. PubMed ID: 12693543 [TBL] [Abstract][Full Text] [Related]
9. Development of a candidate polyvalent live vaccine against human immunodeficiency, hepatitis B, and orthopox viruses. Shchelkunov SN; Nesterov AE; Ryazankin IA; Ignat'ev GM; Sandakhchiev LS Dokl Biochem Biophys; 2003; 390():180-3. PubMed ID: 12959074 [No Abstract] [Full Text] [Related]
10. Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFNγ. Barkhouse DA; Faber M; Hooper DC Virology; 2015 Jan; 474():174-80. PubMed ID: 25463615 [TBL] [Abstract][Full Text] [Related]
11. Development of a reverse genetics system for a human rabies virus vaccine strain employed in China. Huang Y; Tang Q; Nadin-Davis SA; Zhang S; Hooper CD; Ming P; Du J; Tao X; Hu R; Liang G Virus Res; 2010 Apr; 149(1):28-35. PubMed ID: 20080136 [TBL] [Abstract][Full Text] [Related]
12. Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination. Cliquet F; Robardet E; Picard Meyer E Antiviral Res; 2013 Oct; 100(1):84-9. PubMed ID: 23899697 [TBL] [Abstract][Full Text] [Related]
13. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines. Franka R; Wu X; Jackson FR; Velasco-Villa A; Palmer DP; Henderson H; Hayat W; Green DB; Blanton JD; Greenberg L; Rupprecht CE Vaccine; 2009 Nov; 27(51):7149-55. PubMed ID: 19925945 [TBL] [Abstract][Full Text] [Related]
14. [Health ethology of the fox and antirabies vaccine in the Italian experience]. Balbo T Parassitologia; 1988; 30(1):13-7. PubMed ID: 3268766 [TBL] [Abstract][Full Text] [Related]
15. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals. Lodmell DL; Esposito JJ; Ewalt LC Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356 [TBL] [Abstract][Full Text] [Related]
16. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Barrett PN; Mundt W; Kistner O; Howard MK Expert Rev Vaccines; 2009 May; 8(5):607-18. PubMed ID: 19397417 [TBL] [Abstract][Full Text] [Related]
17. Antibody response in cattle after vaccination with inactivated and attenuated rabies vaccines. Rodrigues da Silva AC; Caporale GM; Gonçalves CA; Targueta MC; Comin F; Zanetti CR; Kotait I Rev Inst Med Trop Sao Paulo; 2000; 42(2):95-8. PubMed ID: 10810324 [TBL] [Abstract][Full Text] [Related]
18. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant. Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474 [TBL] [Abstract][Full Text] [Related]
19. Efficacy studies on a canarypox-rabies recombinant virus. Taylor J; Trimarchi C; Weinberg R; Languet B; Guillemin F; Desmettre P; Paoletti E Vaccine; 1991 Mar; 9(3):190-3. PubMed ID: 2042391 [TBL] [Abstract][Full Text] [Related]
20. Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine. Biswas S; Reddy GS; Srinivasan VA; Rangarajan PN Hum Gene Ther; 2001 Oct; 12(15):1917-22. PubMed ID: 11589833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]